Results 211 to 220 of about 7,216,417 (314)

Identification of the Minimal Requirements for Binding to the Human Epidermal Growth Factor (EGF) Receptor Using Chimeras of Human EGF and an EGF Repeat of Drosophila Notch [PDF]

, 1998
Monique L.M. van de Poll, Marianne J.H. van Vugt, Anne E.G. Lenferink, E.J.J. van Zoelen   +3 more
openalex   +1 more source

Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances. [PDF]

Front Pharmacol
Han M, Zhou Z, Qian B, Zhang Q, Peng C, Peng F.   +5 more
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting [PDF]

Gretchen Kimmick, Asal Pilehvari, Wen You, Gloribel Bonilla, Roger T. Anderson   +4 more
openalex   +1 more source

Transforming Growth Factor-β Overrides the Adhesion Requirement for Surface Expression of α5β1 Integrin in Normal Rat Kidney Fibroblasts [PDF]

, 1999
Stephen Dalton, Eric Scharf, Gabriela E. Davey, Richard K. Assoian   +3 more
openalex   +1 more source

Plasma placental growth factor as a susceptibility biomarker for longitudinal cognitive change. [PDF]

Alzheimers Dement
VandeBunte AM, Paolillo EW, Hinman JD, Saloner R, Olzinski M, Dutt S, Cadwallader CJ, Diaz VE, Hallgarth S, Rojas JC, Maillard P, Casaletto KB, Kramer JH.   +12 more
europepmc   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Keratinocyte growth factor functions in epithelial induction during seminal vesicle development.

, 1994
Elaine T. Alarid, Jeffrey S. Rubin, Peter Young, Márcio F. Chedid, Dina Ron, Stuart A. Aaronson, Gerald R. Cunha   +6 more
openalex   +2 more sources

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Placental Growth Factor and Female Long-Term Hypertension. [PDF]

J Clin Med
Adank MC, Roeters Van Lennep JE, Benschop L, Roberts JM, Gandley RE, De Rijke YB, Steegers EAP, Schalekamp-Timmermans S.   +7 more
europepmc   +1 more source